Sort by
Keyphrases
Myeloma
100%
Venous Thromboembolism
100%
Genetic Association
100%
Venous Thromboembolic Events
100%
Thalidomide
100%
Targeted Genotyping
100%
SNP
80%
Clinical Trials
40%
Medical Research Council
40%
Eastern Cooperative Oncology Group
40%
Tumor
20%
Tumor Cells
20%
Treatment Response
20%
Genetic Variation
20%
Probe-based
20%
Treatment-related
20%
Metabolism
20%
Molecular Pathways
20%
Multiple Myeloma
20%
DNA Repair
20%
Environmental Factors
20%
Endothelium
20%
Pulmonary Embolism
20%
Microenvironment
20%
Genetic Factors
20%
Peripheral Blood
20%
Functional Regions
20%
Conventional Treatment
20%
Drug Transport
20%
Myeloma Therapy
20%
Molecular Inversion Probes
20%
Cytokine Balance
20%
Single nucleotide Polymorphism chip
20%
Blood DNA
20%
Medicine and Dentistry
Genetic Association
100%
Myeloma
100%
Venous Thromboembolism
100%
Single Nucleotide Polymorphism
100%
Thalidomide
100%
Oncology
40%
Clinical Trial
40%
Medical Research
40%
Microenvironment
20%
Neoplasm
20%
Tumor Cell
20%
Multiple Myeloma
20%
Cytokine
20%
Pulmonary Embolism
20%
Treatment Response
20%
DNA Repair
20%
Environmental Factor
20%
Genetic Variation
20%
Drug Transport
20%
Molecular Inversion Probe
20%
Side Effect
20%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Single Nucleotide Polymorphism
100%
Genetic Association
100%
Clinical Trial
50%
Genetics
25%
Genetic Divergence
25%
Metabolic Pathway
25%
Single-Nucleotide Polymorphism
25%
Genetic Variation
25%
DNA Repair
25%
Molecular Inversion Probe
25%
Drug Transport
25%
Cytokine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Myeloma
100%
Thalidomide
100%
Clinical Trial
40%
Neoplasm
40%
Drug Transport
20%
Cytokine
20%
Lung Embolism
20%
Multiple Myeloma
20%
Side Effect
20%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Genetic Association
100%
Thalidomide
100%
Tumor Cell
20%
Genetic Variation
20%
Drug Transport
20%
Cytokine
20%
Multiple Myeloma
20%
DNA Repair
20%
Susceptibility
20%